Parametric Portfolio Associates’s Heron Therapeutics HRTX Stock Holding History

Parametric Portfolio Associates’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$1.24M	Buy	216,477 +41,299	+24%	+$302K	﹤0.01%	2681
2021 Q4	$1.6M	Sell	175,178 -2,594	-1%	-$26.5K	﹤0.01%	2577
2021 Q3	$1.9M	Buy	177,772 +17,440	+11%	+$212K	﹤0.01%	2468
2021 Q2	$2.49M	Buy	160,332 +29,643	+23%	+$472K	﹤0.01%	2312
2021 Q1	$2.12M	Buy	130,689 +38,574	+42%	+$688K	﹤0.01%	2743
2020 Q4	$1.95M	Buy	92,115 +19,369	+27%	+$337K	﹤0.01%	2668
2020 Q3	$1.08M	Sell	72,746 -499	-0.7%	-$7.79K	﹤0.01%	2881
2020 Q2	$1.08M	Buy	73,245 +4,834	+7%	+$79.4K	﹤0.01%	2887
2020 Q1	$803K	Sell	68,411 -45,549	-40%	-$856K	﹤0.01%	2915
2019 Q4	$2.68M	Buy	113,960 +16,863	+17%	+$373K	﹤0.01%	2497
2019 Q3	$1.8M	Buy	97,097 +39,223	+68%	+$722K	﹤0.01%	2698
2019 Q2	$1.08M	Buy	57,874 +17,186	+42%	+$343K	﹤0.01%	3016
2019 Q1	$994K	Buy	40,688 +3,176	+8%	+$83.1K	﹤0.01%	3031
2018 Q4	$973K	Sell	37,512 -33,643	-47%	-$925K	﹤0.01%	2993
2018 Q3	$2.25M	Sell	71,155 -35,280	-33%	-$1.31M	﹤0.01%	2628
2018 Q2	$4.13M	Sell	106,435 -6,047	-5%	-$193K	﹤0.01%	2124
2018 Q1	$3.1M	Buy	112,482 +56,643	+101%	+$1.28M	﹤0.01%	2285
2017 Q4	$1.01M	Buy	55,839 +10,749	+24%	+$175K	﹤0.01%	3019
2017 Q3	$728K	Buy	45,090 +11,218	+33%	+$176K	﹤0.01%	3213
2017 Q2	$469K	Buy	33,872 +733	+2%	+$10.6K	﹤0.01%	3401
2017 Q1	$497K	Buy	33,139 +15,394	+87%	+$213K	﹤0.01%	3205
2016 Q4	$232K	Sell	17,745 -3,102	-15%	-$48.7K	﹤0.01%	3538
2016 Q3	$359K	Buy	20,847 +9,029	+76%	+$168K	﹤0.01%	3338
2016 Q2	$213K	Buy	+11,818	New	+$231K	﹤0.01%	3585
2016 Q1	–	Sell	-49,894	Closed	-$1.33M	–	4004
2015 Q4	$1.33M	Buy	49,894 +24,517	+97%	+$656K	﹤0.01%	2559
2015 Q3	$619K	Buy	25,377 +15,865	+167%	+$529K	﹤0.01%	2608
2015 Q2	$296K	Buy	+9,512	New	+$179K	﹤0.01%	3581